MK0916

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Type 2HypertensionMetabolic Syndrome

Phase 2

Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)

CompletedNCT00274716

Merck Sharp & Dohme LLCHypertension

Start: 2005-11-30End: 2007-01-31Updated: 2015-07-03

MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)

CompletedNCT00543595

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2, Metabolic Syndrome

Start: 2004-08-31End: 2005-05-31Updated: 2015-05-22